Trial Profile
Evaluating Lorcaserin Drug Therapy For ICU-Acquired Weakness: A Pilot Randomized Trial
Status:
Discontinued
Phase of Trial:
Phase I/II
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Lorcaserin (Primary) ; Lorcaserin (Primary)
- Indications Muscle weakness
- Focus Therapeutic Use
- Acronyms EMILI
- 26 Dec 2019 Status changed from recruiting to discontinued.
- 14 Dec 2018 Planned End Date changed from 1 Dec 2018 to 1 Dec 2019.
- 14 Dec 2018 Planned primary completion date changed from 1 Dec 2018 to 1 Dec 2019.